Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar A Arias

Showing results (291-300 of 309) with videos related to

Pageof 31
Sort By:
Open Forum Infectious Diseases|February 14, 2022
Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)German A Contreras, Jose M Munita, Shelby Simar, et al.
Genome Biology|July 10, 2008
Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RFAgathe Bourgogne, Danielle A Garsin, Xiang Qin, et al.
Open Forum Infectious Diseases|November 16, 2022
Clinical Impact of Ceftriaxone Resistance in <i>Escherichia coli</i> Bloodstream Infections: A Multicenter Prospective Cohort StudyPranita D Tamma, Lauren Komarow, Lizhao Ge, et al.
Mbio|January 4, 2018
Range Expansion and the Origin of USA300 North American Epidemic Methicillin-Resistant <i>Staphylococcus aureus</i>Lavanya Challagundla, Xiao Luo, Isabella A Tickler, et al.
Transplantation Direct|March 11, 2024
Single-center Outcomes After Liver Transplantation With SARS-CoV-2-Positive Donors: An Argument for Increased UtilizationAshton A Connor, Max W Adelman, Constance M Mobley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
The Journal of Infectious Diseases|July 8, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream InfectionsNatalie A Mackow, Wanying Shao, Lizhao Ge, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> studyLee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
Pageof 31

Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Open Forum Infectious Diseases|February 14, 2022
Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)German A Contreras, Jose M Munita, Shelby Simar, et al.
Genome Biology|July 10, 2008
Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RFAgathe Bourgogne, Danielle A Garsin, Xiang Qin, et al.
Open Forum Infectious Diseases|November 16, 2022
Clinical Impact of Ceftriaxone Resistance in <i>Escherichia coli</i> Bloodstream Infections: A Multicenter Prospective Cohort StudyPranita D Tamma, Lauren Komarow, Lizhao Ge, et al.
Mbio|January 4, 2018
Range Expansion and the Origin of USA300 North American Epidemic Methicillin-Resistant <i>Staphylococcus aureus</i>Lavanya Challagundla, Xiao Luo, Isabella A Tickler, et al.
Transplantation Direct|March 11, 2024
Single-center Outcomes After Liver Transplantation With SARS-CoV-2-Positive Donors: An Argument for Increased UtilizationAshton A Connor, Max W Adelman, Constance M Mobley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
The Journal of Infectious Diseases|July 8, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream InfectionsNatalie A Mackow, Wanying Shao, Lizhao Ge, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> studyLee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
Pageof 31